STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference
Dates:
Format: Presentation available on demand beginning
A link to the presentation will be available on the “Investors” section of the Company’s website at www.strataskinsciences.com.
About
The Company’s proprietary XTRAC® excimer laser delivers a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma diseases which impact over 35 million patients in
STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.
The XTRAC business has used this proven DTC model to grow its domestic dermatology partner network to over 813 clinics, with a worldwide installed base of over 2,000 devices. The Company is able to offer 90% of DTC patients an introduction to physicians prescribing a reimbursable solution, using XTRAC, within a 10-mile radius of their house. The Company is a leader in dermatology in-clinic business generation for its partners.
Investor Contacts:
(415) 937-5404 |
ir@strataskin.com |
Source: STRATA Skin Sciences, Inc.